These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

115 related items for PubMed ID: 23665527

  • 1. Proton magnetic resonance spectroscopy measures related to short-term symptomatic outcome in chronic schizophrenia.
    Szulc A, Konarzewska B, Galinska-Skok B, Lazarczyk J, Waszkiewicz N, Tarasow E, Milewski R, Walecki J.
    Neurosci Lett; 2013 Jun 28; 547():37-41. PubMed ID: 23665527
    [Abstract] [Full Text] [Related]

  • 2. Proton magnetic resonance spectroscopy study of brain metabolite changes after antipsychotic treatment.
    Szulc A, Galinska B, Tarasow E, Waszkiewicz N, Konarzewska B, Poplawska R, Bibulowicz D, Simonienko K, Walecki J.
    Pharmacopsychiatry; 2011 Jun 28; 44(4):148-57. PubMed ID: 21710405
    [Abstract] [Full Text] [Related]

  • 3. The effect of risperidone on metabolite measures in the frontal lobe, temporal lobe, and thalamus in schizophrenic patients. A proton magnetic resonance spectroscopy (1H MRS).
    Szulc A, Galinska B, Tarasow E, Dzienis W, Kubas B, Konarzewska B, Walecki J, Alathiaki AS, Czernikiewicz A.
    Pharmacopsychiatry; 2005 Sep 28; 38(5):214-9. PubMed ID: 16189748
    [Abstract] [Full Text] [Related]

  • 4. Supplementation of Antipsychotic Treatment with the Amino Acid Sarcosine Influences Proton Magnetic Resonance Spectroscopy Parameters in Left Frontal White Matter in Patients with Schizophrenia.
    Strzelecki D, Podgórski M, Kałużyńska O, Gawlik-Kotelnicka O, Stefańczyk L, Kotlicka-Antczak M, Gmitrowicz A, Grzelak P.
    Nutrients; 2015 Oct 22; 7(10):8767-82. PubMed ID: 26506383
    [Abstract] [Full Text] [Related]

  • 5. N-acetylaspartate (NAA) levels in selected areas of the brain in patients with chronic schizophrenia treated with typical and atypical neuroleptics: a proton magnetic resonance spectroscopy (1H MRS) study.
    Szulc A, Galińska B, Tarasów E, Kubas B, Dzienis W, Konarzewska B, Poplawska R, Tomczak AA, Czernikiewicz A, Walecki J.
    Med Sci Monit; 2007 May 22; 13 Suppl 1():17-22. PubMed ID: 17507880
    [Abstract] [Full Text] [Related]

  • 6. Proton magnetic resonance spectroscopy changes after antipsychotic treatment.
    Szulc A, Galinska-Skok B, Waszkiewicz N, Bibulowicz D, Konarzewska B, Tarasow E.
    Curr Med Chem; 2013 May 22; 20(3):414-27. PubMed ID: 23157634
    [Abstract] [Full Text] [Related]

  • 7. [The influence of atypical antipsychotics on brain functioning in schizophrenia. A proton magnetic resonance study].
    Szulc A, Galińiska B, Tarasów E, Dzienis W, Kubas B, Konarzewska B, Waszkiewicz N, Popławska R.
    Psychiatr Pol; 2010 May 22; 44(3):415-26. PubMed ID: 20672520
    [Abstract] [Full Text] [Related]

  • 8. Neuronal dysfunction of the frontal lobe in schizophrenia.
    Pae CU, Choe BY, Joo RH, Lim HK, Kim TS, Yoo SS, Choi BG, Kim JJ, Lee SJ, Lee C, Paik IH, Lee CU.
    Neuropsychobiology; 2004 May 22; 50(3):211-5. PubMed ID: 15365217
    [Abstract] [Full Text] [Related]

  • 9. Duration of untreated psychosis and proton magnetic resonance spectroscopy (1H-MRS) findings in first-episode schizophrenia.
    Galińska B, Szulc A, Tarasów E, Kubas B, Dzienis W, Czernikiewicz A, Walecki J.
    Med Sci Monit; 2009 Feb 22; 15(2):CR82-88. PubMed ID: 19179972
    [Abstract] [Full Text] [Related]

  • 10. Adding Sarcosine to Antipsychotic Treatment in Patients with Stable Schizophrenia Changes the Concentrations of Neuronal and Glial Metabolites in the Left Dorsolateral Prefrontal Cortex.
    Strzelecki D, Podgórski M, Kałużyńska O, Stefańczyk L, Kotlicka-Antczak M, Gmitrowicz A, Grzelak P.
    Int J Mol Sci; 2015 Oct 15; 16(10):24475-89. PubMed ID: 26501260
    [Abstract] [Full Text] [Related]

  • 11. Cognitive impairment and in vivo metabolites in first-episode neuroleptic-naive and chronic medicated schizophrenic patients: a proton magnetic resonance spectroscopy study.
    Ohrmann P, Siegmund A, Suslow T, Pedersen A, Spitzberg K, Kersting A, Rothermundt M, Arolt V, Heindel W, Pfleiderer B.
    J Psychiatr Res; 2007 Oct 15; 41(8):625-34. PubMed ID: 16949099
    [Abstract] [Full Text] [Related]

  • 12. [Proton magnetic resonance spectroscopy of prefrontal lobe and thalamus in schizophrenics: correlation with clinical characteristics].
    Gan JL, Duan HF, Yang JM, Shi ZJ, Zhang DW, Jiang ZK, Gao CY, Wang ZJ.
    Zhonghua Yi Xue Za Zhi; 2011 Nov 22; 91(43):3034-9. PubMed ID: 22333054
    [Abstract] [Full Text] [Related]

  • 13. Proton magnetic resonance spectroscopy during initial treatment with antipsychotic medication in schizophrenia.
    Bustillo JR, Rowland LM, Jung R, Brooks WM, Qualls C, Hammond R, Hart B, Lauriello J.
    Neuropsychopharmacology; 2008 Sep 22; 33(10):2456-66. PubMed ID: 18094668
    [Abstract] [Full Text] [Related]

  • 14. Supplementation of antipsychotic treatment with sarcosine – GlyT1 inhibitor – causes changes of glutamatergic (1)NMR spectroscopy parameters in the left hippocampus in patients with stable schizophrenia.
    Strzelecki D, Podgórski M, Kałużyńska O, Gawlik-Kotelnicka O, Stefańczyk L, Kotlicka-Antczak M, Gmitrowicz A, Grzelak P.
    Neurosci Lett; 2015 Oct 08; 606():7-12. PubMed ID: 26306650
    [Abstract] [Full Text] [Related]

  • 15. Comparison of Metabolite Concentrations in the Left Dorsolateral Prefrontal Cortex, the Left Frontal White Matter, and the Left Hippocampus in Patients in Stable Schizophrenia Treated with Antipsychotics with or without Antidepressants. ¹H-NMR Spectroscopy Study.
    Strzelecki D, Grzelak P, Podgórski M, Kałużyńska O, Stefańczyk L, Kotlicka-Antczak M, Gmitrowicz A.
    Int J Mol Sci; 2015 Oct 15; 16(10):24387-402. PubMed ID: 26501256
    [Abstract] [Full Text] [Related]

  • 16. Single voxel proton magnetic resonance spectroscopy in post-stroke depression.
    Glodzik-Sobanska L, Slowik A, McHugh P, Sobiecka B, Kozub J, Rich KE, Urbanik A, Szczudlik A.
    Psychiatry Res; 2006 Dec 01; 148(2-3):111-20. PubMed ID: 17088051
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The predictive value of baseline NAA/Cr for treatment response of first-episode schizophrenia: A ¹H MRS study.
    Liu W, Yu H, Jiang B, Pan B, Yu S, Li H, Zheng L.
    Neurosci Lett; 2015 Jul 23; 600():199-205. PubMed ID: 26099422
    [Abstract] [Full Text] [Related]

  • 19. Quantitative magnetic resonance spectroscopy of schizophrenia: relationship between decreased N-acetylaspartate and frontal lobe dysfunction.
    Tanaka Y, Obata T, Sassa T, Yoshitome E, Asai Y, Ikehira H, Suhara T, Okubo Y, Nishikawa T.
    Psychiatry Clin Neurosci; 2006 Jun 23; 60(3):365-72. PubMed ID: 16732755
    [Abstract] [Full Text] [Related]

  • 20. Reduced prefrontal N-acetylaspartate in stroke patients with apathy.
    Glodzik-Sobanska L, Slowik A, Kieltyka A, Kozub J, Sobiecka B, Urbanik A, Szczudlik A.
    J Neurol Sci; 2005 Nov 15; 238(1-2):19-24. PubMed ID: 16084528
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.